[EN] 6-SUBSTITUTED PHENOXYCHROMAN CARBOXYLIC ACID DERIVATIVES<br/>[FR] DÉRIVÉS DE L'ACIDE CARBOXYLIQUE PHÉNOXYCHROMANE SUBSTITUÉS EN 6
申请人:ARRAY BIOPHARMA INC
公开号:WO2009158426A1
公开(公告)日:2009-12-30
Compounds of Formula (I): in which A1, A2, W, L, G, R7a, R7b, R8, R9 and R10 have the meanings given in the specification, are DP2 receptor modulators useful in the treatment of immunologic diseases.
.beta.-Adrenergic blocking agents. 18. 1-(Aryloxy)-3-(arylthioalkylamino)propan-2-ols and 1-substituted alkylthioamino-3-(aryloxy)propan-2-ols
作者:H. Tucker、J. F. Coope
DOI:10.1021/jm00206a010
日期:1978.8
The synthesis is described of a seris of derivaties of 1-(aryloxy)-3-(arylthioalkylamiho)propan-2-ols and 1-(alkylthioamino)- and 1-(aralkylamino)-3-(aryloxy)propan-2-ols. These compounds were investigated for their beta-adrenoreceptor blocking properties and their selectivity of action for the cardiac beta1 receptor. The structure-activity relationships are discussed with particular reference to the
Compounds of Formula (I): in which A
1
, A
2
, W, L, G, R
7a
, R
7b
, R
8
, R
9
and R
10
have the meanings given in the specification, are DP2 receptor modulators useful in the treatment of immunologic diseases.